中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2009年
7期
1238-1239
,共2页
哮喘%沙美特罗%丙酸氟替卡松%儿童
哮喘%沙美特囉%丙痠氟替卡鬆%兒童
효천%사미특라%병산불체잡송%인동
asthma%salmeterol xinafoate%fluticasone propianate%children
目的 观察沙美特罗与丙酸氟替卡松治疗儿童咳嗽变异性哮喘的疗效和安全性.方法 将65例咳嗽变异性哮喘息儿随机分为治疗组32例和对照组33例.对照组予氨茶碱口服,治疗组予沙美特罗/丙酸氟替卡松粉吸入剂治疗.结果 显效率治疗组为56%,对照组为27%,两组差异有显著性(P<0.05).治疗组和对照组的总有效率分别为97%和77%,两组差异也有统计学意义(P<0.05).未见明显不良反应.结论 沙美特罗/丙酸氟替卡松粉吸入剂治疗儿童咳嗽变异性哮喘疗效好,使用方便.
目的 觀察沙美特囉與丙痠氟替卡鬆治療兒童咳嗽變異性哮喘的療效和安全性.方法 將65例咳嗽變異性哮喘息兒隨機分為治療組32例和對照組33例.對照組予氨茶堿口服,治療組予沙美特囉/丙痠氟替卡鬆粉吸入劑治療.結果 顯效率治療組為56%,對照組為27%,兩組差異有顯著性(P<0.05).治療組和對照組的總有效率分彆為97%和77%,兩組差異也有統計學意義(P<0.05).未見明顯不良反應.結論 沙美特囉/丙痠氟替卡鬆粉吸入劑治療兒童咳嗽變異性哮喘療效好,使用方便.
목적 관찰사미특라여병산불체잡송치료인동해수변이성효천적료효화안전성.방법 장65례해수변이성효천식인수궤분위치료조32례화대조조33례.대조조여안다감구복,치료조여사미특라/병산불체잡송분흡입제치료.결과 현효솔치료조위56%,대조조위27%,량조차이유현저성(P<0.05).치료조화대조조적총유효솔분별위97%화77%,량조차이야유통계학의의(P<0.05).미견명현불량반응.결론 사미특라/병산불체잡송분흡입제치료인동해수변이성효천료효호,사용방편.
Objective To investigate the effect of salmeterol xinafoate and fluticasone propionate in treat-ment of children's cough variant asthma(CVA) and its safety. Methods Sixty-five children with CVA were ran-domly divided into treatment group (n = 32) and control group (n = 33). The control group was given orally amin-ophylline, and the treatment group was treated with salmeterol xinafoate and fluticasone propionate powder for inhala-tion. Results The improving rate of treatment group was significantly higher than that of control group (56% vs 27%, P < 0.05). The total effective rate of treatment group was significantly higher than that of control group (97% vs 77%, P < 0.05), and few side effects occurred. Conclusion It is effective and convenient that salmeterol xin-afoate and fluticasone propionate powder for inhalation in treatment of children' s CVA.
